{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:27:27Z","timestamp":1791178047204,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1016\/j.expneurol.2003.08.007","type":"journal-article","created":{"date-parts":[[2003,10,22]],"date-time":"2003-10-22T12:20:53Z","timestamp":1066825253000},"page":"536-548","source":"Crossref","is-referenced-by-count":79,"title":["Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus)"],"prefix":"10.1016","volume":"184","author":[{"given":"Andisheh","family":"Eslamboli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalyn M","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind M","family":"Ridley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry F","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Muzyczka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Kirik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy E","family":"Annett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2003.08.007_BIB1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn812","article-title":"The GDNF family","volume":"3","author":"Airaksinen","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/nbdi.2001.0456","article-title":"Neuropathological and behavioral consequences of adeno-associated viral vector-mediated continuous intrastriatal neurotrophin delivery in a focal ischemia model in rats","volume":"9","author":"Andsberg","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/brain\/115.3.825","article-title":"Behavioural analysis of unilateral monoamine depletion in the marmoset","volume":"115","author":"Annett","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2003.08.007_BIB4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/bies.950170310","article-title":"The cryptic life style of adeno-associated virus","volume":"17","author":"Berns","year":"1995","journal-title":"Bioessays"},{"key":"10.1016\/j.expneurol.2003.08.007_BIB5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0891-0618(01)00115-6","article-title":"Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain","volume":"21","author":"Chauhan","year":"2001","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB6","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1128\/JVI.71.11.8780-8789.1997","article-title":"Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap","volume":"71","author":"Conway","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0014-2999(00)00933-X","article-title":"Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets","volume":"412","author":"Costa","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0891-0618(01)00139-9","article-title":"Topographical localization of glial cell line-derived neurotrophic factor in the human brain stem","volume":"23","author":"Del-Fiacco","year":"2002","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB9","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1097\/00001756-199708180-00017","article-title":"PET studies of functional compensation in a primate model of Parkinson's disease","volume":"8","author":"Eberling","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2003.08.007_BIB10","doi-asserted-by":"crossref","unstructured":"Eslamboli, A., Baker, H.F., Ridley, R.M., Annett, L.E., 2003. Sensorimotor deficits in a unilateral intrastriatal 6-OHDA partial lesion model of Parkinson's disease in marmoset monkeys. Exp. Neurol. 183, 418\u2013429","DOI":"10.1016\/S0014-4886(03)00139-0"},{"key":"10.1016\/j.expneurol.2003.08.007_BIB11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0306-4522(84)90259-8","article-title":"Localization of nigrostriatal, nigrothalamic and nigrotectal neurons in ventricular coordinates in macaques","volume":"13","author":"Francois","year":"1984","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2003.08.007_BIB12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/exnr.1996.6387","article-title":"From transplants to gene therapy for Parkinson's disease","volume":"144","author":"Freeman","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/380252a0","article-title":"Functional recovery in parkinsonian monkeys treated with GDNF","volume":"380","author":"Gash","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2003.08.007_BIB14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/exnr.2002.8006","article-title":"Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer","volume":"177","author":"Georgievska","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00001756-200201210-00019","article-title":"Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector","volume":"13","author":"Georgievska","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2003.08.007_BIB16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm850","article-title":"Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease","volume":"9","author":"Gill","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","article-title":"The efficiency of systematic sampling in stereology and its prediction","volume":"147","author":"Gundersen","year":"1987","journal-title":"J. Microsc."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/exnr.2000.7571","article-title":"Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin","volume":"168","author":"Hamilton","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0306-4522(00)00326-2","article-title":"Immunohistochemical localization of glial cell line-derived neurotrophic factor in the human central nervous system","volume":"100","author":"Kawamoto","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2003.08.007_BIB20","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1523\/JNEUROSCI.17-18-07111.1997","article-title":"GDNF protection against 6-OHDA","volume":"17","author":"Kearns","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0006-8993(94)01366-P","article-title":"GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo","volume":"672","author":"Kearns","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB22","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1046\/j.0953-816x.2001.01534.x","article-title":"Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease","volume":"13","author":"Kirik","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB24","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1523\/JNEUROSCI.20-12-04686.2000","article-title":"Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model","volume":"20","author":"Kirik","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB25","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1523\/JNEUROSCI.21-08-02889.2001","article-title":"Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration","volume":"21","author":"Kirik","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB26","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1126\/science.290.5492.767","article-title":"Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease","volume":"290","author":"Kordower","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2003.08.007_BIB27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0006-8993(97)01100-1","article-title":"Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease","volume":"777","author":"Lapchak","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0306-4522(97)83045-X","article-title":"Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats","volume":"78","author":"Lapchak","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2003.08.007_BIB29","series-title":"Handbook of Chemical Neuroanatomy, Vol. 13. The Primate Nervous System. Part 1","first-page":"263","article-title":"Dopamine systems in the primate brain","author":"Lewis","year":"1997"},{"key":"10.1016\/j.expneurol.2003.08.007_BIB30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/exnr.1999.7203","article-title":"Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease","volume":"160","author":"Mandel","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB31","doi-asserted-by":"crossref","first-page":"14083","DOI":"10.1073\/pnas.94.25.14083","article-title":"Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats","volume":"94","author":"Mandel","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2003.08.007_BIB32","first-page":"97","article-title":"Use of adeno-associated virus as a general transduction vector for mammalian cells","volume":"158","author":"Muzyczka","year":"1992","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s004410050688","article-title":"Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system","volume":"286","author":"Nosrat","year":"1996","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB34","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1523\/JNEUROSCI.22-12-04942.2002","article-title":"Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration","volume":"22","author":"Palfi","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB35","series-title":"The Development of Human Gene Therapy","first-page":"131","article-title":"Adeno-associated viral vectors","author":"Samulski","year":"1999"},{"key":"10.1016\/j.expneurol.2003.08.007_BIB36","series-title":"The Brain of the Common Marmoset (Callithrix jacchus), A Stereotaxic Atlas","author":"Stephan","year":"1980"},{"key":"10.1016\/j.expneurol.2003.08.007_BIB37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1460-9568.1998.00016.x","article-title":"Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo","volume":"10","author":"Sullivan","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.gt.3301682","article-title":"Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease","volume":"9","author":"Wang","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB39","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ar.1092310411","article-title":"Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator","volume":"231","author":"West","year":"1991","journal-title":"Anat. Rec."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/nbdi.2002.0499","article-title":"L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease","volume":"10","author":"Winkler","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/104303401300042500","article-title":"CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice","volume":"12","author":"Xu","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB42","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.gt.3300938","article-title":"Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield","volume":"6","author":"Zolotukhin","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2003.08.007_BIB43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0165-0173(01)00098-4","article-title":"Sustained delivery of GDNF","volume":"36","author":"Zurn","year":"2001","journal-title":"Brain Res. Brain Res. Rev."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488603004114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488603004114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T05:55:25Z","timestamp":1585202125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488603004114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0014488603004114"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2003.08.007","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}